Sanofi sues Sarepta, claiming Duchenne gene therapy Elevidys infringes 2 manufacturing patents

Six months after surviving a patent challenge involving its $3.2 million gene therapy, Sarepta faces a new lawsuit from another gene therapy developer claiming the approved treatment infringes its active patents.